Review

A New Player in Chronic Kidney Disease: Asymmetric Dimethylarginine (ADMA)

Volume 16 · Issue 3 Publish Date: February 18, 2019
Full Text PDF
Mahmut İlker YILMAZ
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
Tayfun EYİLETEN
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
Müjdat YENİCESU
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
YILMAZ, M. İlker, EYİLETEN, T., & YENİCESU, M. (2019). A New Player in Chronic Kidney Disease: Asymmetric Dimethylarginine (ADMA). Turkish Journal of Nephrology, 16(3), 93–101. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/601
Full Text Full Text PDF

Abstract

-

Similar Articles

Article Info
Published In
Journal Turkish Journal of Nephrology
Volume / Issue Volume 16 · Issue 3
Pages 93-101
History
Published Online February 18, 2019
Copyright
Affiliations
Mahmut İlker YILMAZ
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
Tayfun EYİLETEN
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
Müjdat YENİCESU
Gülhane Askeri Tıp Akademisi, Nefroloji BD, Ankara
Cite this Article
YILMAZ, M. İlker, EYİLETEN, T., & YENİCESU, M. (2019). A New Player in Chronic Kidney Disease: Asymmetric Dimethylarginine (ADMA). Turkish Journal of Nephrology, 16(3), 93–101. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/601
Outlines